Tag: Covaxin

Covaxin
COVID Vaccine: Bharat Biotech Begins Human Trial Of Covaxin In India

Chandigarh: The human trial of Bharat Biotech’s anti-COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted. In his tweet, the minister also said the vaccine has been administered to three persons who have shown no adverse effect to it. “Human trial with Corona vaccine (COVAXIN) […]

  • Thursday, 15 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
AIIMS To Begin COVID Vaccine Human Trial From Next Week

New Delhi: In a major development, AIIMS Delhi will begin human trials of India’s first indigenous Covid-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55. The volunteers will be kept under observation for a period of nearly 150 days. Covaxin is developed by Bharat Biotech in collaboration with the […]

  • Wednesday, 14 April 2021
COVID19 Vaccine in India
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine

New Delhi: At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally. Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological […]

  • Wednesday, 14 April 2021
Covaxin-clinical Trail
Clinical Trials Of COVID Vaccine Set To Start In Bhubaneswar From Wednesday

Bhubaneswar: Human clinical trials of the country’s indigenously developed COVID-19 vaccine is set to begin this week at a Bhubaneswar-based institute — one of the 12 centres selected by the ICMR for conducting phase one and two of the process, a senior official said. The human trials of BBV152 COVID Vaccine or Covaxin will begin […]

  • Wednesday, 14 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
COVID-19 Vaccine: Animal Study Proved Vax's Efficacy, Says Bharat Biotech

Hyderabad: Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the vaccine in a live viral challenge model. “Bharat Biotech proudly announces the animal study results of COVAXIN – These results demonstrate the protective efficacy in […]

  • Monday, 12 April 2021
covaxin
Covid Vaccine Alert: Phase III Trials Of Covaxin In Odisha Soon

Bhubaneswar: The third and final phase of the ongoing clinical trials of Covaxin – India’s indigenous Covid-19 vaccine candidate will shortly begin in Odisha. The Phase III trials of Covaxin will be conducted at 21 centres across India and at SUM hospital in Odisha (Bhubaneswar). The vaccine will be administered to nearly 2,000 volunteers in […]

  • Saturday, 10 April 2021
Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials
Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials

Hyderabad: Bharat Biotech, which recently received approval to conduct Phase III human trials of India’s first indigenous coronavirus vaccine, Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in […]

  • Saturday, 10 April 2021
COVAXIN
COVID-19 Vaccine Likely By February 2021!

Bhubaneswar: With scientists across the world working overtime to prepare a vaccine for Covid-19 by the year end, it is expected that the vaccine could be introduced in India as early as February,2021. Speculations became rife after Bharat Biotech’s Covid-19 vaccine candidate showed safety and efficacy during the phase 1 and 2 trials as well […]

  • Friday, 09 April 2021
Bharat Biotech: Vaccinating 130Cr People With Covaxin A Challenge
Bharat Biotech: Vaccinating 130Cr People With Covaxin A Challenge

Hyderabad: Bharat Biotech on Monday raised the logistical query on “how to vaccinate 1.3 billion (130 crore) people with two injectable doses of India’s first indigenous coronavirus vaccine Covaxin”. Terming the exercise a “challenge” it also said that work was on single-dose nasal drop vaccine. Bharat Biotech’s comment comes while Covaxin is entering its third […]

  • Friday, 09 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
Covaxin's Phase-3 Trials Begin: Bharat Biotech

Hyderabad: Phase-3 trials of Covaxin, India’s first indigenous vaccine for Covid-19 commenced today, vaccine maker Bharat Biotech announced on Monday. The Phase-3 trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). This is India’s first Phase-3 efficacy study for a Covid-19 vaccine, and the […]

  • Friday, 09 April 2021
Odisha: Phase-3 Human Trials Of Covaxin Begins At SUM Hospital
Odisha: Phase-3 Human Trials Of Covaxin Begins At SUM Hospital

Bhubaneswar: The third phase human trial of Covid-19 vaccine candidate ‘Covaxin’ began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Friday. This is the only institute in the State chosen by the Indian Council for Medical Research (ICMR) for the human trial of the vaccine. The vaccine was administered to two […]

  • Friday, 09 April 2021
PM Modi Reviews Preparedness Of COVID19 Vaccine Delivery

New Delhi: Prime Minister Narendra Modi, today reviewed the preparedness of Covid-19 vaccine delivery, distribution and administration. Prime Minister appreciated the efforts of innovators, scientists, academicians and pharma-companies in their efforts to develop vaccines and has directed that every effort should be made to facilitate the research, development and manufacturing of the vaccine. Five vaccines […]

  • Friday, 09 April 2021
Oxford Covid-19 Vaccine ‘Encouraging' For Older Age Groups
Covid-19 Vaccine: Odisha May Face Cold Chain Challenge

Bhubaneswar: Even as the race of potential vaccine for Covid-19 is approaching the last lap, the cold-chain infrastructure is likely to emerge as biggest hurdle for Odisha, say experts. The State government has started a road map in full swing for procurement, preservation and distribution of the vaccine as Prime Minister Narendra Modi on Friday […]

  • Friday, 09 April 2021
Oxford AstraZeneca Vaccine 70% Effective In Preventing COVID19
All Eyes Now On Covid-19 Vaccine Availability

New Delhi/Bhubaneswar: Of all the Covid vaccine candidates, who will be the first to achieve a near-complete efficacy is what everyone awaits now. On Monday, the university of Oxford achieved a significant milestone in the fight against Covid. Interim data shows the Oxford vaccine is 70.4 per cent effective, while tests on two dose regimens […]

  • Friday, 09 April 2021
Haryana Minister Anil Vij
Anil Vij Took Only 1st Dose Of Double-Dose Covid Vaccine, Clarifies Health Ministry

New Delhi: Hours after Haryana Home and Health Minister Anil Vij, who was administered a dose of Covaxin last month, confirmed that he has been tested positive for coronavirus infection, the Union Health Ministry on Saturday clarified that Vij took only the first dose of the two-dose vaccine. “The antibodies against the infection build up […]

  • Thursday, 08 April 2021
scrollToTop